Found: 9
Select item for more details and to access through your institution.
Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer.
- Published in:
- Oncology, 2000, v. 58, n. 1, p. 25, doi. 10.1159/000012075
- By:
- Publication type:
- Article
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 332, doi. 10.3390/cancers13020332
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
- Published in:
- Journal of Cellular Physiology, 2018, v. 233, n. 3, p. 2313, doi. 10.1002/jcp.26103
- By:
- Publication type:
- Article
Management of radiation-induced oral mucositis in head and neck cancer patients: a real-life survey among 25 Italian radiation oncology centers.
- Published in:
- Supportive Care in Cancer, 2024, v. 32, n. 1, p. 1, doi. 10.1007/s00520-023-08185-5
- By:
- Publication type:
- Article
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Antipyrine metabolism in patients with liver metastases from colorectal cancer.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer.
- Published in:
- Gastric Cancer, 2007, v. 10, n. 2, p. 104, doi. 10.1007/s10120-007-0415-x
- By:
- Publication type:
- Article
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 7, p. 1917, doi. 10.1002/ijc.32583
- By:
- Publication type:
- Article